Colin Marr

As President of Phyton Biotech Ltd., and operating from corporate headquarters in Fort Worth, Texas, Colin Marr provides overall leadership to the Phyton Biotech organization across Europe, North America, and Asia, representing DFB Pharmaceuticals and its shareholders through strategies for growth and investment in pharmaceuticals and biotechnology.

In 2016, Colin joined Phyton Biotech in the Vancouver operations as Vice President, Business Development to bring renewed growth of Phyton Biotech’s capabilities and assets. Before joining Phyton Biotech Colin enjoyed many years with BioVectra Inc. as Director, Business Development and prior to that with its subsidiary as Director of Business Development with Atlantis BioActives Corporation. Colin has also held the position of Vice President Sales and Marketing with Island Critical Care, Director of Biotechnology and Life Sciences with Enterprise PEI, and Director of Development with the PEI Food Technology Centre.

Colin holds a Master of Science in Oceanography from McGill University in Montreal, Quebec, and a Hons. BSc. in Physiology/Pharmacology from Western University in London, Ontario.